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Abstract
Background: Multiple sclerosis (MS) is a neurological disorder with a highly characteristic disease distribution. Prevalence
and incidence in general increase with increasing distance from the equator. Similarly the female to male sex ratio increases
with increasing latitude. Multiple possible risk factors have been hypothesised for this epidemiological trend, including
human leukocyte antigen allele frequencies, ultraviolet exposure and subsequent vitamin D levels, smoking and Epstein-
Barr virus. In this study we undertook a study of medical records across Scotland on an NHS health board level of resolution
to examine the epidemiology of MS in this region.
Methods and Results: We calculated the number and rate of patient-linked hospital admissions throughout Scotland
between 1997 and 2009 from the Scottish Morbidity Records. We used weighted-regression to examine correlations
between these measures of MS, and latitude and smoking prevalence. We found a highly significant relationship between
MS patient-linked admissions and latitude (r weighted by standard error (rsw) = 0.75, p = 0.002). There was no significant
relationship between smoking prevalence and MS patient-linked admissions.
Discussion: There is a definite latitudinal effect on MS risk across Scotland, arising primarily from an excess of female MS
patients at more Northerly latitudes. Whether this is a true gradient or whether a threshold effect may apply at particular
latitude will be revealed only by further research. A number of genetic and environmental factors may underlie this effect.
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Introduction
Multiple sclerosis (MS) is a complex neurological disorder
characterised by demyelination and axonal loss.[1] MS shows a
marked variation by latitude throughout the world, with increasing
prevalence and incidence with increasing distance from the
equator.[2,3] This latitudinal effect has been observed in a large
number of different studies in the Northern hemisphere and also
holds true in the Southern hemisphere. Much of this latitude
gradient appears to stem from an excess of female MS patients at
higher latitudes.[4,5]
Multiple genetic and environmental risk factors have been
hypothesised to underlie the distribution of MS, including human
leukocyte antigen (HLA) allele frequencies, ultraviolet radiation
and vitamin D levels, smoking, and infection with Epstein-Barr
virus.[6,7,8,9] It is likely that many of these interact together on a
population-wide level to determine MS prevalence and inci-
dence.[8,10,11]
The Northern parts of Scotland have previously been shown to
have a particularly high prevalence of MS.[12] This appears to be
responsible for much of the latitudinal variation in MS across the
United Kingdom.[13] However recent data on the prevalence of
MS in Scotland is not available. Given suggestions that the latitude
gradient in MS is decreasing,[5] we undertook an analysis of MS
hospital admissions stratified by NHS health board in Scotland in
order to examine epidemiological trends in MS in fine detail.
Methods
Data on hospital admissions for MS between 1997 and 2009
were analysed using a file of linked hospital admission statistics,
built from the Scottish Morbidity Records (SMR01) system.
SMR01 records all inpatient and day case discharges from non-
obstetric and non-psychiatric specialties in NHS Hospitals in
Scotland. Probability matching methods have been used to link
together individual hospital records for each patient, thereby
creating ‘‘linked’’ patient histories. Up to six diagnoses (1 principal,
5 secondary) are recorded on SMR01 returns. All six diagnoses
have been used to select Multiple Sclerosis. The following code
was used from the International Statistical Classification of
Diseases and Other Health Problems, tenth revision (ICD10):
Multiple Sclerosis - G35. These diagnoses are made by the
lead physician responsible for each patient’s care during the
admission.
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We show data for the areas of the 14 Scottish Strategic Health
Boards. MS indirect admission rates were calculated using
observed average annual numbers of MS patients from each area
with one or more hospital admissions as the numerators and the
expected number of average annual MS admissions from census
data as the denominators, before multiplying this by the overall
MS admissions rate for Scotland. Using data linkage, we identified
each person only once for MS, regardless of how many admissions
each person had, and recorded their residence at first known
admission for MS. To adjust for differences in the age structure of
different areas, age-standardisation was undertaken using the
indirect method and the age-specific rates in the Scottish
population. All rates are expressed per 100 000 population with
95% lower and upper confidence limits. Rates were calculated
separately for males and females as well as both sexes combined.
We also calculated rates for other autoimmune diseases (rheuma-
toid arthritis, ulcerative colitis, Crohn’s disease and type 1 diabetes
mellitus) and a neurological disease (motor neuron disease).
Table 1. Overall admissions data for MS in Scotland between 1997 and 2009.
NHS board of residence
Observed patients
(13 year total)
Expected patients
(13 year total)
Average
yearly
observed
patients
Average
yearly
expected
patients
Indirect
rate per
100,000
Lower
95% CI
Upper
95% CI
NHS Ayrshire & Arran 949 816.20 73.00 62.78 19.62 10.94 28.30
NHS Borders 202 246.32 15.54 18.95 13.84 6.55 21.13
NHS Dumfries & Galloway 341 336.33 26.23 25.87 17.11 9.00 25.22
NHS Fife 793 769.55 61.00 59.20 17.39 9.22 25.56
NHS Forth Valley 455 612.48 35.00 47.11 12.54 5.60 19.47
NHS Grampian 1,377 1,153.98 105.92 88.77 20.14 11.34 28.93
NHS Greater Glasgow & Clyde 2,190 2,567.77 168.46 197.52 14.39 6.96 21.83
NHS Highland 900 682.03 69.23 52.46 22.27 13.02 31.52
NHS Lanarkshire 1,051 1,206.56 80.85 92.81 14.70 7.18 22.21
NHS Lothian 1,611 1,688.84 123.92 129.91 16.10 8.23 23.96
NHS Orkney Islands 97 43.78 7.46 3.37 37.38 25.40 49.37
NHS Shetland Islands 72 47.70 5.54 3.67 25.47 15.58 35.36
NHS Tayside 844 851.46 64.92 65.50 16.73 8.71 24.74
NHS Western Isles 73 59.02 5.62 4.54 20.87 11.92 29.83
Scotland 11,094 853 16.87
doi:10.1371/journal.pone.0014606.t001
Table 2. Male only admissions data for MS in Scotland between 1997 and 2009.
NHS board of residence
Observed patients
(13 year total)
Expected patients
(13 year total)
Average
yearly
observed
patients
Average
yearly
expected
patients
Indirect rate per
100,000
Lower
95% CI
Upper
95% CI
NHS Ayrshire & Arran 304 248.12 23.38 19.09 13.10 6.01 20.19
NHS Borders 56 76.82 4.31 5.91 7.79 2.32 13.27
NHS Dumfries & Galloway 97 104.87 7.46 8.07 9.89 3.73 16.05
NHS Fife 244 235.52 18.77 18.12 11.08 4.55 17.60
NHS Forth Valley 128 187.04 9.85 14.39 7.32 2.02 12.62
NHS Grampian 393 363.14 30.23 27.93 11.57 4.90 18.24
NHS Greater Glasgow & Clyde 691 768.40 53.15 59.11 9.62 3.54 15.69
NHS Highland 280 214.20 21.54 16.48 13.98 6.65 21.30
NHS Lanarkshire 314 363.61 24.15 27.97 9.23 3.28 15.19
NHS Lothian 503 510.87 38.69 39.30 10.53 4.17 16.89
NHS Orkney Islands 27 13.93 2.08 1.07 20.72 11.80 29.64
NHS Shetland Islands 23 15.43 1.77 1.19 15.94 8.11 23.76
NHS Tayside 246 261.03 18.92 20.08 10.08 3.85 16.30
NHS Western Isles 22 19.01 1.69 1.46 12.38 5.48 19.27
Scotland 3,384 260.31 10.69
doi:10.1371/journal.pone.0014606.t002
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Smoking data was obtained from the Atlas of Tobacco Smoking
in Scotland, produced by the NHS Health Scotland, ISD Scotland
and ASH Scotland.[14] Population smoking prevalence estimates
were used from 2003/2004 and were based upon all age groups
combined. Latitudes for each NHS health board were defined as
the latitude of the administrative centre for that health board. As
anonymised data were used we followed the ethical principles of
existing UK data protection legislation and guidance, including
two National Statistics (NS) Protocols on Data Access and
Confidentiality, and Data Matching and so specific ethical
approval was not required for this study.
We performed Pearson and linear weighted regression to
compare the admissions for MS, latitude and smoking using
MATLAB R2009a. Least-squared weighted regression was
conducted based both on standard error estimates and a weighting
value derived from NHS health board population numbers. x2
tests were used to compare observed and expected hospital
admissions throughout Scottish health boards.
Results
MS admissions by NHS health board
The overall number of patients admitted with MS (as an
absolute value over the 13 year period and a yearly average) and
indirect rate per 100,000 population are shown in table 1.
Overall 11,094 individual patients were admitted with MS in
Scotland between 1997 and 2009. This was equivalent to a yearly
average of 853 and an indirect rate of 16.87 per 100,000
population. However, it was clear that the admission rates varied
considerably between NHS health boards, with the highest rate in
NHS Orkney Islands (37.38 [95% CI 25.40–49.37]) and the
lowest in NHS Forth Valley (12.54 [95% CI 5.60–19.47]).
Table 3. Female only admissions data for MS in Scotland between 1997 and 2009.
NHS board of residence
Observed
patients (13
year total)
Expected patients
(13 year total)
Average yearly
observed
patients
Average
yearly
expected
patients
Indirect rate
per 100,0001
Lower
95% CI
Upper
95% CI
NHS Ayrshire & Arran 645 571.39 49.62 43.95 25.55 15.64 35.46
NHS Borders 146 168.92 11.23 12.99 19.56 10.90 28.23
NHS Dumfries & Galloway 244 231.09 18.77 17.78 23.90 14.32 33.48
NHS Fife 551 534.60 42.38 41.12 23.33 13.86 32.80
NHS Forth Valley 328 426.61 25.23 32.82 17.40 9.23 25.58
NHS Grampian 984 778.81 75.69 59.91 28.60 18.12 39.08
NHS Greater Glasgow & Clyde 1,501 1,812.62 115.46 139.43 18.74 10.26 27.23
NHS Highland 620 463.55 47.69 35.66 30.27 19.49 41.06
NHS Lanarkshire 738 848.58 56.77 65.28 19.69 10.99 28.38
NHS Lothian 1,110 1,180.19 85.38 90.78 21.29 12.25 30.33
NHS Orkney Islands 70 29.41 5.38 2.26 53.88 39.49 68.27
NHS Shetland Islands 49 31.32 3.77 2.41 35.42 23.75 47.08
NHS Tayside 598 591.78 46.00 45.52 22.87 13.50 32.25
NHS Western Isles 51 39.14 3.92 3.01 29.50 18.85 40.14
Scotland 7,718 594 22.64
doi:10.1371/journal.pone.0014606.t003
Figure 1. Scatter plots of MS admission rates against latitude. (A) Overall data. (B) Male (blue) and female (red) specific data.
doi:10.1371/journal.pone.0014606.g001
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The data for male and female patients admitted with MS are
shown in tables 2 and 3. The indirect rate for MS in females
across Scotland was significantly higher than in males (males 10.69
vs. females 22.64, x2 = 4.28, d.f. = 1, p = 0.04).
Correlation of MS admissions with latitude
Overall MS hospital admissions showed a strong correlation
with latitude (figure 1a; r = 0.76, p = 0.001; r weighted by SE
(rsw) = 0.75, p= 0.002; r weighted by population (rpw) = 0.71,
p = 0.004). This held true when analysed separately by gender,
although the male data was not significant when weighted by
population (figure 1b; males – r = 0.77, p= 0.001; rsw = 0.74,
p = 0.002; rpw = 0.52, p = 0.06; females – r = 0.77, p = 0.001;
rsw = 0.76, p = 0.002; rpw = 0.76, p= 0.001).
Correlation of MS admissions with smoking prevalence
There was a nominally significant inverse correlation with
smoking but this was lost in the weighted regression (figure 2a;
overall – r =20.55, p = 0.04, rsw =20.49, p= 0.08; rpw =20.25,
p = 0.39; figure 2b; males – r =20.52, p = 0.06, rsw =20.47,
p = 0.09; rpw =20.21, p = 0.47; females – r =20.56, p = 0.04;
rsw =20.49, p = 0.08; rpw =20.25, p = 0.38).
Sex ratio
There was no significant correlation between the sex ratio and
latitude in MS patient-linked admissions except when weighted by
population (figure 3; r = 0.32, p= 0.27; rsw = 0.41, p = 0.15,
rpw = 0.75, p = 0.002). There was no relationship between the sex
ratio and smoking prevalence (r = 0.27, p = 0.36; rsw = 0.36,
p = 0.21; rpw = 0.14, p= 0.64).
Other autoimmune and neurological diseases
There was no significant overall correlation between indirect
admissions rate and latitude for several autoimmune diseases (data
not shown; rheumatoid arthritis – rsw = 0.29, p = 0.39; Crohn’s
disease – rsw = 0.06, p = 0.81; type 1 diabetes mellitus – rsw = 0.26,
p = 0.37) or a neurological disease (motor neuron disease –
rsw = 0.26, p = 0.37). Indirect admissions rates for ulcerative colitis
did show a nominally significant correlation with latitude
(rsw = 0.57, p = 0.03) but this was lost after correction for multiple
hypothesis testing.
Discussion
We present here the most up to date available map of the
distribution of MS in Scotland. Our findings have shown that the
latitude gradient of MS prevalence and incidence observed still exists
in Scotland.[2] As suggested by previous work,[2] much of this
latitude gradient is as a result of an increase in female MS risk at
increasing latitudes. It must be noted, however, that, although our
data does support a latitudinal gradient, the data itself could also
argue for a ‘‘threshold’’ effect around 57uN. Until more is
understood about the aetiological origin for this effect of latitude
onMS prevalence, conclusions regarding this must remain tentative.
Smoking does not appear to underlie this latitudinal effect,
especially given the apparent inverse correlation of smoking
prevalence with latitude. Although there is some suggestion that
the sex-ratio in MS admissions may be inversely related to
smoking prevalence, this is quite unlikely to be a real effect given
that where MS risk is highest (NHS Orkney Islands), smoking
prevalence is lowest and so, regardless of the ratio between male
and female smoking behaviour, it is difficult to envision how the
absence of a susceptibility factor could result in a sex-specific
increase of disease risk.[15] There are clear limitations in using
background population measures of smoking prevalence as a
surrogate for exposure in patients with MS. In particular, effects
on the level of individual patients will not be detected in this sort of
population-based data. Future studies should re-examine this
question in relation to MS-specific smoking data.
Limitations of record linkage studies using routinely collected
administrative data are well known, and include the facts that the
Figure 2. Scatter plots of MS admission rates against smoking prevalence. (A) Overall data. (B) Male (blue) and female (red) specific data.
doi:10.1371/journal.pone.0014606.g002
Figure 3. Scatter plots of female-to-male sex-ratio of MS
admission rates against latitude.
doi:10.1371/journal.pone.0014606.g003
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data are limited to hospitalised patients and that information
about some variables of potential interest, such as social
circumstances and ethnicity, are generally unavailable. It is also
worth noting that the sample size of regions primarily driving the
latitudinal effect (e.g. the Orkney and Shetland Islands) and
relatively small and so this effect will need to be confirmed in
future work. The fact that latitudinal effects were not seen for
other autoimmune and neurological diseases argues strongly
against the gradient we observed being solely due to underlying
trends in hospital services or background population admissions
rates.
The environmental risk factor that most likely explains the
latitudinal effect observed in this study is the effect of ultraviolet
irradiation on vitamin D biosynthesis. Vitamin D deficiency has
already been associated with risk of MS and controls the
expression of HLA-DRB1*1501, the key genetic risk factor in
MS.[10,16] However, it is likely that MS prevalence will be
explained only by considering a complex interplay of genetic and
environmental risk factors, some of which may not yet have been
identified [8].
The latitudinal variation in MS prevalence may have important
implications for neurological service provision. For example,
although the number of MS-relevant clinics per week correlates
well with the total number of admissions as one would expect with
the tendency of admissions to follow hospital resources (r = 0.69,
p,0.01), these show a trend towards inverse correlation with MS
indirect admissions rates, probably a better estimate of back-
ground disease prevalence (r =20.52, p = 0.06) [17]. MS disease
distribution should be considered when evaluating neurology
services in Scotland in the future.
In conclusion, the distribution of MS across Scotland shows
nearly three-fold variation, at least as measured by hospitalisation
rates. The higher rates in the North than South of Scotland persist;
they are consistent with earlier findings from studies in different
parts of the UK; and they are consistent with the more general
finding across the world that MS prevalence increases with
increasing distance from the equator in both hemispheres. The
high prevalence of MS in the North of Scotland should be
recognised in funding of care for MS and for studies of disease
prevention.
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